Monash IVF Group Limited
MNIVF
$0.40
-$0.11-21.57%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.02% | -2.87% | 11.60% | 14.21% | 15.64% |
| Total Other Revenue | -151.10% | -150.20% | -29.08% | -27.57% | -27.18% |
| Total Revenue | -1.19% | -3.05% | 11.57% | 14.17% | 15.56% |
| Cost of Revenue | -1.10% | -2.96% | 12.95% | 15.59% | 17.34% |
| Gross Profit | -1.38% | -3.23% | 8.98% | 11.52% | 12.01% |
| SG&A Expenses | 25.79% | 23.43% | 2.64% | 5.03% | 4.08% |
| Depreciation & Amortization | 20.64% | 18.38% | 13.39% | 16.04% | 18.76% |
| Other Operating Expenses | -93.80% | -93.91% | -192.34% | -194.50% | 2,789.18% |
| Total Operating Expenses | -27.06% | -28.43% | 6.11% | 8.59% | 65.71% |
| Operating Income | 161.75% | 160.59% | 39.99% | 43.26% | -231.57% |
| Income Before Tax | 139.75% | 139.01% | 38.10% | 41.33% | -285.77% |
| Income Tax Expenses | 132.95% | 132.33% | 48.04% | 51.51% | -338.70% |
| Earnings from Continuing Operations | 143.21% | 142.40% | 34.35% | 37.49% | -266.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.81% | 24.27% | -174.50% | -181.43% | -754.85% |
| Net Income | 140.27% | 139.52% | 33.17% | 36.28% | -270.04% |
| EBIT | 161.75% | 160.59% | 39.99% | 43.26% | -231.57% |
| EBITDA | 191.28% | 210.11% | 31.39% | 34.46% | -199.49% |
| EPS Basic | 140.49% | 139.26% | 32.71% | 36.45% | -269.79% |
| Normalized Basic EPS | 138.00% | 137.33% | 40.22% | 43.48% | -264.84% |
| EPS Diluted | 140.00% | 138.79% | 30.84% | 34.58% | -271.88% |
| Normalized Diluted EPS | 138.00% | 137.33% | 40.66% | 42.39% | -264.84% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.12% | 0.12% | -0.61% |
| Dividend Per Share | -100.00% | -100.00% | 13.33% | 16.00% | 21.92% |
| Payout Ratio | 3.51% | 3.51% | -0.15% | -0.15% | -1.66% |